This site became the new on June 19th. Learn more.
Show more Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu
Give us feedback

Mindfulness Meditation Training in HIV (MBSR)

This study has been completed.
Information provided by:
University of California, Los Angeles Identifier:
First received: January 14, 2008
Last updated: NA
Last verified: January 2008
History: No changes posted
The purpose of this study is to investigate whether Mindfulness-Based Stress Reduction (MBSR) vs a one-day MBSR seminar improves immune (CD4+ T lymphocytes) and virological (HIV viral load) status in HIV-1 infected adults. The secondary goal of the study is to determine if MBSR vs a one-day MBSR seminar improves self-reported HIV-related quality of life.

Condition Intervention Phase
HIV Infections Behavioral: MBSR Phase 2

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single (Outcomes Assessor)
Primary Purpose: Treatment
Official Title: Biobehavioral Effects of Mindfulness-Based Stress Reduction in HIV

Resource links provided by NLM:

Further study details as provided by University of California, Los Angeles:

Primary Outcome Measures:
  • CD4+ T lymphocytes (counts) [ Time Frame: Pre-test and post-test ]

Secondary Outcome Measures:
  • HIV-related Quality of Life [ Time Frame: Pre-test and post-test ]
  • HIV viral load [ Time Frame: Pre-test and post-test ]

Enrollment: 50
Study Start Date: June 2005
Study Completion Date: January 2008
Primary Completion Date: December 2007 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Active Comparator: 1-Day MBSR
One-day condensed MBSR class
Behavioral: MBSR
Mindfulness-Based Stress Reduction Intervention
Other Names:
  • mindfulness meditation
  • attention training
Experimental: 8-week MBSR
8-week Mindfulness-Based Stress Reduction Intervention
Behavioral: MBSR
Mindfulness-Based Stress Reduction Intervention
Other Names:
  • mindfulness meditation
  • attention training

Detailed Description:

Mindfulness meditation, which is described as a process of bringing awareness to moment-to-moment experience, has been receiving substantial scientific attention as a process that can be stress and health protective (Brown, Ryan, & Creswell, 2007). Recent reviews by Baer (2003), Bishop (2002), and Grossman et al (2004) support the effectiveness of the standardized and manualized MBSR program in reducing stress and functional disability in a variety of chronic illnesses, although no studies have tested if MBSR impacts clinical markers of HIV, although some evidence suggests that MBSR improves some markers of innate immunity and quality of life in HIV-infected adults (see Robinson, Mathews, & Witek-Janusek, 2003). In this study, we propose to extend this work by investigating the impact of this intervention on biological and functional health status in HIV-positive adults.

We propose to determine whether the 8-week MBSR program is more effective than a one-day MBSR seminar in: (1) maintaining immune resistance in HIV infection (i.e. maintaining counts of CD4+ T lymphocytes and reducing HIV viral load), and (2) improving HIV-related quality of life. Additional analyses will test for a dose-response effect of MBSR by examining if MBSR class attendance and daily meditation practice are associated with the primary and secondary outcomes. These aims will be tested in a sample of 50 HIV-positive adults that is diverse with respect to ethnicity, gender and sexual orientation.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • Diagnosed HIV for > 6 months
  • English speaking
  • 18 years old or older
  • Indicate some distress (>4 on the Patient Health Questionnaire-9)
  • Willing to be randomized

Exclusion Criteria:

  • Any substance abuse or treatment for a psychiatric disorder in the past 30 days
  • Currently diagnosed with AIDS or had CD4+ T lymphocytes <200 cells
  • Hepatitis (A, B, or C)
  • Indicate a regular mind-body practice (e.g., yoga, meditation) in the past six months
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00600561

United States, California
Cousins Center for Psychoneuroimmunology, UCLA
Los Angeles, California, United States, 90095
Sponsors and Collaborators
University of California, Los Angeles
Principal Investigator: Hector F Myers, PhD UCLA Department of Psychology
Study Director: J. David Creswell, PhD Cousins Center for Psychoneuroimmunology, UCLA
  More Information

Publications automatically indexed to this study by Identifier (NCT Number):
Responsible Party: Hector F. Myers, PhD, UCLA Department of Psychology Identifier: NCT00600561     History of Changes
Other Study ID Numbers: MBSR-HIV-Trial-Seedgrant
M01RR000865 ( U.S. NIH Grant/Contract )
Study First Received: January 14, 2008
Last Updated: January 14, 2008

Keywords provided by University of California, Los Angeles:
Complementary Therapies

Additional relevant MeSH terms:
HIV Infections
Lentivirus Infections
Retroviridae Infections
RNA Virus Infections
Virus Diseases
Sexually Transmitted Diseases, Viral
Sexually Transmitted Diseases
Immunologic Deficiency Syndromes
Immune System Diseases processed this record on September 21, 2017